TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
Rachel A. Freedman(Dana-Farber Cancer Institute), Nancy U. Lin(Dana-Farber Cancer Institute), Julie R. Nangia(Unknown), Carey K. Anders(Duke University), Beverly Moy(Global Cancer Institute), Rachel C. Jankowitz(University of Pennsylvania), Paula R. Pohlmann(The University of Texas MD Anderson Cancer Center), Antonio C. Wolff(Johns Hopkins University), Juan M. Marte(Dana-Farber Cancer Institute), Ian E. Krop(Yale Cancer Center), Catherine Van Poznak(University of Michigan), Polly Niravath(Houston Methodist), Nadine Tung(Beth Israel Deaconess Medical Center), Kelly M. Silvestri(Dana-Farber Cancer Institute), Robyn Burns(Breast Cancer Research Foundation), Ciara C. O’Sullivan(Mayo Clinic in Arizona), Timothy J. Moynihan(Mayo Clinic), Rebecca Gelman(Dana-Farber Cancer Institute), Eric P. Winer(University of Vermont), Kathryn P. Componeschi(Dana-Farber Cancer Institute), Mothaffar F. Rimawi(Baylor College of Medicine), Karen L. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nuhad K. Ibrahim(The University of Texas MD Anderson Cancer Center), Christine M. Cotter(Dana-Farber Cancer Institute), Heather A. Parsons(Harvard University), Shannon L. Puhalla(NSABP Foundation), Anne B. Cropp(Pfizer (United States)), Michelle Melisko(University of California, San Francisco), Kimberly Blackwell(Duke University), Roisín M. Connolly(Johns Hopkins University)
Cited by 341
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
The Seattle Heart Failure Model
|Circulation|2006|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k